Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Pérez-Gómez A, et al. Among authors: vitalle j. Cell Mol Immunol. 2021 Sep;18(9):2128-2139. doi: 10.1038/s41423-021-00728-2. Epub 2021 Jul 21. Cell Mol Immunol. 2021. PMID: 34290398 Free PMC article.
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response.
Pérez-Gómez A, Gasca-Capote C, Vitallé J, Ostos FJ, Serna-Gallego A, Trujillo-Rodríguez M, Muñoz-Muela E, Giráldez-Pérez T, Praena-Segovia J, Navarro-Amuedo MD, Paniagua-García M, García-Gutiérrez M, Aguilar-Guisado M, Rivas-Jeremías I, Jiménez-León MR, Bachiller S, Fernández-Villar A, Pérez-González A, Gutiérrez-Valencia A, Rafii-El-Idrissi Benhnia M, Weiskopf D, Sette A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 and COHVID-GS Working Teams. Pérez-Gómez A, et al. Among authors: vitalle j. Clin Transl Med. 2022 Apr;12(4):e802. doi: 10.1002/ctm2.802. Clin Transl Med. 2022. PMID: 35415890 Free PMC article.
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, Vitallé J, Peraire J, Palacios-Baena ZR, Cabrera JJ, Ruiz-Mateos E, Poveda E, López-Cortés LE, Rull A, Gutierrez-Valencia A, López-Cortés LF. Trujillo-Rodriguez M, et al. Among authors: vitalle j. PLoS One. 2022 Jul 14;17(7):e0269875. doi: 10.1371/journal.pone.0269875. eCollection 2022. PLoS One. 2022. PMID: 35834501 Free PMC article.
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people.
Vitallé J, Pérez-Gómez A, Ostos FJ, Gasca-Capote C, Jiménez-León MR, Bachiller S, Rivas-Jeremías I, Silva-Sánchez MDM, Ruiz-Mateos AM, Martín-Sánchez MÁ, López-Cortes LF, Rafii-El-Idrissi Benhnia M, Ruiz-Mateos E. Vitallé J, et al. JCI Insight. 2022 Sep 8;7(17):e161045. doi: 10.1172/jci.insight.161045. JCI Insight. 2022. PMID: 35943812 Free PMC article.
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression.
Álvarez H, Ruiz-Mateos E, Juiz-González PM, Vitallé J, Viéitez I, Vázquez-Friol MDC, Torres-Beceiro I, Pérez-Gómez A, Gallego-García P, Estévez-Gómez N, De Chiara L, Poveda E, Posada D, Llibre JM. Álvarez H, et al. Among authors: vitalle j. Microorganisms. 2022 Jan 11;10(1):143. doi: 10.3390/microorganisms10010143. Microorganisms. 2022. PMID: 35056592 Free PMC article.
Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers.
Vitallé J, Terrén I, Gamboa-Urquijo L, Orrantia A, Tarancón-Díez L, Genebat M, Ruiz-Mateos E, Leal M, García-Obregón S, Zenarruzabeitia O, Borrego F. Vitallé J, et al. Front Immunol. 2018 Jul 23;9:1709. doi: 10.3389/fimmu.2018.01709. eCollection 2018. Front Immunol. 2018. PMID: 30083165 Free PMC article.
CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients.
Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F. Vitallé J, et al. Cell Mol Immunol. 2019 Dec;16(12):940-942. doi: 10.1038/s41423-019-0275-4. Epub 2019 Aug 29. Cell Mol Immunol. 2019. PMID: 31467415 Free PMC article. No abstract available.
29 results